Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Antibiotic Management of Lung Infections in Cystic Fibrosis. II. Nontuberculous Mycobacteria, Anaerobic Bacteria, and Fungi.
[allergic bronchopulmonary aspergillosis]
Airway
infections
are
a
key
component
of
cystic
fibrosis
(
CF
)
lung
disease
.
Whereas
the
approach
to
common
pathogens
such
as
Pseudomonas
aeruginosa
is
guided
by
a
significant
body
of
evidence
,
other
infections
often
pose
a
considerable
challenge
to
treating
physicians
.
In
Part
I
of
this
series
on
the
antibiotic
management
of
difficult
lung
infections
,
we
discussed
bacterial
organisms
including
methicillin-resistant
Staphylococcus
aureus
,
gram-negative
bacterial
infections
,
and
treatment
of
multiple
bacterial
pathogens
.
Here
,
we
summarize
the
approach
to
infections
with
nontuberculous
mycobacteria
,
anaerobic
bacteria
,
and
fungi
.
Nontuberculous
mycobacteria
can
significantly
impact
the
course
of
lung
disease
in
patients
with
CF
,
but
differentiation
between
colonization
and
infection
is
difficult
clinically
as
coinfection
with
other
micro-organisms
is
common
.
Treatment
consists
of
different
classes
of
antibiotics
,
varies
in
intensity
,
and
is
best
guided
by
a
team
of
specialized
clinicians
and
microbiologists
.
The
ability
of
anaerobic
bacteria
to
contribute
to
CF
lung
disease
is
less
clear
,
even
though
clinical
relevance
has
been
reported
in
individual
patients
.
Anaerobes
detected
in
CF
sputum
are
often
resistant
to
multiple
drugs
,
and
treatment
has
not
yet
been
shown
to
positively
affect
patient
outcome
.
Fungi
have
gained
significant
interest
as
potential
CF
pathogens
.
Although
the
role
of
Candida
is
largely
unclear
,
there
is
mounting
evidence
that
Scedosporium
species
and
Aspergillus
fumigatus
,
beyond
the
classical
presentation
of
allergic
bronchopulmonary
aspergillosis
,
can
be
relevant
in
patients
with
CF
and
treatment
should
be
considered
.
At
present
,
however
there
remains
limited
information
on
how
best
to
select
patients
who
could
benefit
from
antifungal
therapy
.
Diseases
Validation
Diseases presenting
"gram-negative bacterial infections"
symptom
allergic bronchopulmonary aspergillosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom